We assume that further research involving a larger number of DH patients and newly emerging test systems for detection of other transglutaminase antibodies (TG3 and/or TG6) would clarify the findings presented in the current study and may have a significant impact on the clinical practice. This evidence concerns the gene TGM6 and dermatitis herpetiformis, familial.